Macquarie Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
NAMI
Macquarie Group's NEO Position: Q4 2025 in Review
Macquarie Group sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 2,542,339 shares — an estimated $19.6M sold.
Macquarie Group first reported a position in NEO in Q4 2018 and held it in 24 quarters. The position peaked at $98.5M in Q3 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.
- Macquarie Group reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
- Macquarie Group sold 2,542,339 NeoGenomics shares in Q4 2025, an estimated $19.6M.
- Macquarie Group first reported a position in NeoGenomics in Q4 2018 and held it in 24 quarters.
- Macquarie Group's NeoGenomics position peaked at $98.5M in Q3 2021.
- 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.
Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.